Trials / Completed
CompletedNCT06908915
Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectatic Facial Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hawler Medical University · Academic / Other
- Sex
- All
- Age
- 32 Years – 52 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical study is to assess the effectiveness of Nd:YAG laser 1064 nm in the long pulse mode in the treatment of signs of rosacea including the erythema of the face and telangiectasia. The used parameter of this laser was of very low energy (spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 millijoules (mJ) and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval) and also its was expected to have minimal adverse effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nd:YAG laser 1064 nm | The entire face of each patient with rosacea was treated with long-pulse 1064nm Nd:YAG laser. The parameters that been used were spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 mJ and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval. |
Timeline
- Start date
- 2023-03-03
- Primary completion
- 2023-11-01
- Completion
- 2024-11-04
- First posted
- 2025-04-03
- Last updated
- 2025-04-03
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT06908915. Inclusion in this directory is not an endorsement.